The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
I'm also looking forward to finding out what the Spanish video production was about. Joining dots, I'd speculate we're targeting South America with a view to getting a nice call-off order like our NHS order. You don't produce a video for 10,000 tests, they're aiming for a large order...
We could buy Optigene with the cash we have sat in our bank. They're a relatively small outfit a bit like PrimerDesign was when Novacyt bought them.
https://companycheck.co.uk/company/06465874/OPTIGENE-LIMITED/financials#key-financials
Sales update won't be until end of next week IMO, July 1st next wed and a day or two to confirm all the sales.
Spit tests have a months trial, a lot of competition for AVCT it seems - not in the bag for them either.
Something decent will happen in the US sooner or later. Our new products give us a USP that might allow Bruker or Thermofisher to get an angle for some decent sales...faster tests and reagents for other tests if they're short of reagents...
Another poster that says he's underwater and constantly moans about the SP. Why not spend some time researching and post any useful links that might help drive the SP up?
Or are you another none-invested deramper?
Alan,
My comment was in response to Mehta.ck who said the below. I was pointing out that investors have responded to our all time low because we've bounced off 207p lows and increased our MCAP circa £21M since then. FYI I've been here since end of Feb and haven't sold a bean.
"If thats the case and it being at all time low, all investors should flock here, what’s wrong?"
Mehta.ck, are you our resident new deramper? Looking at your posts you have nothing positive to say...
The share price rose from lows of 207p to our current 238p, that's £21M cash that's come our way in the last few days.
Hani, what's the point deramping your own stock? Patience required and we'll re-rate when the market catches up with the profit and cash in our bank. New products will add revenue streams and there is additional manufacturing capacity for them separate than our existing 10M units per month. Mobile testing coming online in July too.